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Abstract 
Oral intake of ascorbic acid (AA) is essential for optimum health in human beings. CAPD patients have an 
increased need for ascorbic acid, as there are increased losses through the dialysate, reduced intake due to 
nausea and loss of appetite, and increased oxidative stress. The optimum intake however is still controversial. 
Fifty clinically stable patients were studied to determine the relationship between their oral intake and serum 
ascorbic acid (SAA) levels. The oral intake ranged from 28-412 mg/day. Only one patient had oral intake 
<60mg/day. SAA ranged from 1-36.17 mg/L. Although there was strong correlation (p<0.001, R2=0.47) 
between intake and SAA, the variation of SAA at any given intake level was wide. Sixty two percent of patients 
had SAA<8.7mg/L, 40% had SAA<5.1mg/L (below level of healthy population), and 12% had levels <2mg/L 
(scorbutic). None of the patients demonstrated clinical manifestations of scurvy. Our results show that in CAPD 
patients, deficiency of ascorbic acid can only be detected reliably with SAA measurements and that oral intake 
may influence levels of SAA. To maintain the AA in the normal range for healthy adults the oral intake of AA 
needs to be increased above the US RDA to 80-140mg/day. 
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Introduction 
AA is involved in the formation and repair of collagen, development of bones and teeth, amino acid metabolism 
and the synthesis of hormones (1), wound healing and facilitates iron absorption and utilization in. AA is also 
an important plasma antioxidant. Patients undergoing CAPD are at great risk to become deficient in AA 
because of inadequate dietary intake (due to nausea and loss of appetite), altered metabolism in uremia and loss 
into dialysate (2). Oxidative stress may possibly increase the requirement for AA to maintain normal levels of 
serum AA. The serum levels of AA have been reported to be low in some studies of dialysis patients (3, 4). 
Supplementation with AA has been recommended but an optimum dose has yet to be determined as excessive 
intake of AA may cause hyperoxalemia in dialysis patients (2). 
Objective:  
We therefore conducted a cross sectional study on clinically stable CAPD patients to determine the relationship 
between serum ascorbic acid and daily oral ascorbic acid intake. 
Patients and methods 
Patients: Fifty patients aged 18 years and above who were on peritoneal dialysis for at least 3 months (mean 22 
+ 26 months) were selected for study (Table I). Patients with the following were excluded: current peritonitis or 
peritonitis within the last 4 weeks, a history of renal calculous disease, a smoking history.  
Methods 
Measurement of Serum Ascorbic Acid: Venous blood samples of patients were analysed for serum ascorbic 
acid (SAA) by HPLC with UV detection at 245 nm according to the procedure by L. S. Liau, et.al., 1993 (5). 
Oral ascorbic acid intake: Patients were given a 3-day food diary chart with appropriate instructions. On the 
fourth day, patients were interviewed on their food diaries. Food items and amounts were verified using food 
models. Dietary AA intake were calculated using NutriGenie Total Nutrition v4.8 software and data for local 
foods not available in the software were entered based on nutrient analyses from the Singapore Food Facts 1999 
and Nutrient Composition of Malaysian Foods - 4th edition (6).  All supplements containing AA were taken into 
account and patients’ total AA intakes were then obtained by adding the dietary intake and the oral 
supplementation of AA.  
Statistical methods: Data was analysed by SPSS 10.0 windows. The bivariate correlation coefficient was 
calculated between SAA and oral AA intake. A p value <0.05 was considered as significant. 
Results 
Ascorbic acid obtained from diet in our CAPD patients ranged from 7 – 215 mg per day (mean: 67 + 51 
mg/day) (Table II). Thirty six percent of our patients did not even take 1 serving of fruit per day, 42% 
consumed 1 serving of fruit and only 22% ate 2 servings of fruit per day (Figure 2). All except 5 patients was on 
AA supplements of between 50 –360 mg per day (Figure 3). The total oral intake (AA from diet + AA 
supplements) ranged from 28 to 412 mg/day (Table II). Only one patient had total oral intake less than 60 
mg/day. 
SAA levels ranged from 1.00-36.17 mg/L. Although there was strong correlation (p<0.001, R2 =0.47) between 
intake and SAA, the variation of SAA at any given intake level was wide (Figure 1). Sixty two percent of 
patients had SAA<8.7mg/L, 40%had SAA < 5.1mg/L (below level of healthy Singapore adults), and 12% had 
levels <2 mg/L (scorbutic). None of the patients however demonstrated clinical signs or symptoms of scurvy. 
Discussion 
Ascorbic acid has been shown to be essential for health and an important antioxidant in humans (7). It is not 
synthesised and needs to be obtained from dietary intake (8). It is water-soluble, removed through the dialysate 
(9) and serum levels have been shown to be low in several populations of CAPD patients (3, 10).  
The US Recommended Dietary Allowance (RDA) for AA is 60 mg per day for healthy, non-smoking adults 
(11). This amount prevents the development of scurvy for about 1 month with a diet lacking in AA (12). 
Smokers need at least 100mg of AA (1). In our study, we excluded patients who were smokers. The 
requirements for AA is increased in many situations such as wound healing and its  efficacy is reduced by many 
drugs (i.e., tobacco and aspirin) (13). 
Ascorbic acid obtained from diet in our CAPD patients ranged from 7 – 215 mg per day (mean = 67 mg). Fifty-
six percent of our patients had dietary AA intake of less that the US RDA recommendations. Most of our 
patients have a relatively low intake of fresh fruits, which is the diet’s main source of AA. Thirty- six percent 
did not even take 1 serving of fruit per day (Figure 2). However the total oral intake of AA inclusive of 
supplements exceeded 60 mg/day for almost all our patients. The optimum daily requirement needed to prevent 
AA deficiency in CAPD patients is still controversial, as large doses of AA supplementation may lead to 
hyperoxalaemia (14).  
Healthy non-smoking adults in Singapore have SAA levels ranging from 5.1 – 8.7 mg/L(12). The range for 
normal healthy adults in US is 4 to 15 mg/L (15). Our results show that a large proportion of our CAPD patients 
have levels of SAA which are low (<5.1 mg/L) when compared to those found in a culturally comparable 
population without renal failure (16). Possible reasons include:  
1. Reduced intake – due to renal failure (loss of appetite, nausea and easy satiety); and inadequate or 
inappropriate diet preparation. In addition, some patients may still practise some of the pre-dialysis advice of 
potassium restriction which indirectly limits foods that tend to be high in AA, and boiling of vegetables which 
destroys AA. 
2. Increased loss into the dialysate. Dialysate removal of AA rises with intake (3, 17) and can be as much 10.5 
mg/L (3). It has been estimated that 62% of the plasma concentration of AA is lost into the dialysate (3).  
Twelve percent of our patient had SAA levels below scorbutic level (<2 mg/L). The finding that none of the 
patients had signs of scurvy despite low serum AA levels suggests that signs may manifest only late in a 
deficiency state. This may be because the body normally stores about 1500 mg of vitamin C, and clinical signs 
of deficiency do not occur until the body pool is less than 300 mg which may take several weeks (1). Our data 
confirms that early deficiency of ascorbic acid can be detected earlier with SAA measurements. 
Studies in normal populations in the US have shown that serum AA levels and oral intake correlate well until 
the dietary intake reaches 100 –150 mg/day at which point the serum levels plateau at 14 mmol/L (18). In our 
study, the serum levels did plateau with dietary intake of 100 - 150 mg. On the contrary, we found that patients 
taking a higher amount of AA continued to show a higher SAA. The data also showed a strong correlation 
between oral intake of AA and the SAA.(p<0.001, R2 =0.47).  However the variation of SAA at any given 
intake level was very wide. This may be due to the lack of precision in our methods of estimating overall intake 
or may suggest that oral intake is not the only factor influencing SAA. 
All our patients except one had total oral AA intake estimated to be above that of the US RDA of 60mg/day. 
Despite this, 40% of our CAPD patients had serum AA less than 5.1 mg/L. This suggests that the requirement 
for oral intake of AA for CAPD patients to maintain SAA levels comparable to normal healthy adults should be 
more than 60 mg/day. From our data, we conclude that this oral intake level of AA should be 90-140 mg/day 
(fig 1). 
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Figure 1: Scatter plot & Correlation of serum levels 
with daily oral intake of Ascorbic Acid
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Figure 2: Fruit consumption per day among 
CAPD patients
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Figure 3: Ascorbic Acid supplements 
in CAPD patients 
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Table I:  Patient demographics 
Age (mean + SD years)      60.84 + 11.03 years  
Age range (years)     (36 – 81) 
Sex (Male : Female)     24 : 26 
Diabetic status (yes: no)     32 : 18  
Causes of Renal Failure     Diabetes Mellitus      - 64% 
    Glomerulonephritis  -  26% 
    Others                       - 10%  
 
Duration on CAPD     22 + 26 months  
Racial distribution
(Chinese:Indian:Malay)
  
    38 : 5 : 7 
 
 
 
 
 
 
 
 
 
 
 
 Table II:  Oral intake and serum levels of Ascorbic Acid 
Parameters  Range Mean  +  SD 
Ascorbic acid from diet (mg/day) 7 – 215  67  + 51  
Ascorbic acid from supplements (mg/day) 50 – 360  93  + 83  
Total ascorbic acid intake  (mg/day) 28 – 412  160  + 100  
Serum ascorbic acid (mg/L) 1.00 -36.17  9.44 + 8.80      
 
 
 
   
 
 
 
 
 
